Twenty-eight patients with lung cancer, 26 with extensive disease, were treated with the drugs Cytoxan (Cyt) and methotrexate (MTX). The schedule was based on cellular kinetics concepts. Initial therapy was with Cyt 1.1 g/m2 (intravenously) followed by MTX 20 mg/m2 orally, twice weekly, started 9 da
β¦ LIBER β¦
Advanced epidermoid lung cancer. Prolonged survival after chemotherapy
β Scribed by Frederick Richards II; M. Robert Cooper; Douglas R. White; Hyman B. Muss; Don V. Jackson; John J. Stuart; Charles L. Spurr
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 788 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Combination chemotherapy in advanced lun
β
Dr. Marc J. Straus
π
Article
π
1976
π
John Wiley and Sons
π
English
β 844 KB
Advanced colorectal cancer: Impact of ch
β
Enrico Cortesi; Augusto Padovani; Alessandra Aloe; Vincenzo Picece; Patrizia Pel
π
Article
π
1991
π
John Wiley and Sons
π
English
β 355 KB
Combination chemotherapy of advanced lun
β
Heine H. Hansen; Oleg S. Selawry; Richard Simon; David T. Carr; C. E. van Wyk; R
π
Article
π
1976
π
John Wiley and Sons
π
English
β 503 KB
Evaluation of survival after second-line
β
M. Steven Piver; Fernando O. Recio; Trudy R. Baker; Deborah Driscoll
π
Article
π
1994
π
John Wiley and Sons
π
English
β 493 KB
π 2 views
Five-year lung cancer survival : Which a
β
Tina Wang; Rebecca A. Nelson; Alicia Bogardus; Frederic W. Grannis Jr
π
Article
π
2010
π
John Wiley and Sons
π
English
β 133 KB
π 1 views
Replication competent Semliki Forest vir
β
Ann-Marie MÀÀttÀ; Kimmo MÀkinen; Anna Ketola; Timo Liimatainen; Felicitas Newu Y
π
Article
π
2008
π
John Wiley and Sons
π
French
β 387 KB
## Abstract We evaluated the therapeutic potential of the replication competent vector VA7βEGFP, which is based on the avirulent Semliki Forest virus (SFV) strain A7 (74) carrying the __EGFP__ marker gene in an orthotopic lung cancer tumor model in nude mice. We have previously shown that this onco